CAMBRIDGE, Mass.--(BUSINESS WIRE)--T2 Biosystems, Inc., a company developing the first point-of-care medical diagnostic products that enable rapid molecular and immunodiagnostic testing on a single instrument, today announced, that it will be participating in a session on new diagnostics for the new healthcare system, taking place at the 2010 BIO International Convention in Chicago.
